Dr Rosa Nadal is a Medical Oncologist at the National Cancer Institute at the National Institutes of Health in Bethesda, Maryland, USA. Dr Nadal graduated in Medicine and Surgery in 2000 at the Universidad Autònoma de Barcelona in Spain. She completed her Medical Oncology Fellowship at the Hospital de San Pau, a teaching hospital of the Universidad Autònoma de Barcelona. Dr Nadal completed her certification for clinical research and then studied tumour biology and development of biomarkers. Dr Nadal defended her PhD thesis at the Universitat Autònoma de Barcelona, graduating Cum Laude; she was recognised for outstanding academic achievement with the PhD Extraordinary Award. After completing her oncology training, she joined the faculty at the Solid Tumor Oncology Service of Hospital de Barcelona in 2007 and had an active clinical and translational research career, as well as a busy practice caring for patients with advanced genitourinary cancers, under the guidance of her clinical mentor, Dr Joaquim Bellmunt. From February 2012 to June 2015, she joined a genitourinary fellowship programme to gain additional training on the management of prostate cancer and biomarker development, specifically the clinical validation of the AR-V7, at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital in Baltimore, Maryland, USA.
Her clinical focus is the management of genitourinary advanced cancers of the kidney and urinary tract, including bladder cancer. She works closely with a multidisciplinary team to develop molecularly targeted cancer therapies and novel adoptive cell therapies, with a special focus on kidney cancer and bladder cancer. Dr Nadal has authored several original scientific and medical articles in peer reviewed journals.